Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 30Recruiting 21Terminated 17Unknown 12Active not recruiting 9Not yet recruiting 8Withdrawn 4Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 10Hematologic Neoplasms 7Leukemia 6Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms 3Immunoblastic Lymphadenopathy 3Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Pain, Intractable 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Multiple Myeloma 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1

Interventions

fludarabine 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasm, Residual × Other hematologic neoplasm × Clear all
NCT03494569 2026-03-18

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center

Phase 1 Suspended
36 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡